| Date Filed | Type | Description |
| 09/08/2021 |
REVOKED
| Form REVOKED - Commission order revoking Exchange Act registration [Section 12(j)]: |
| 04/21/2017 |
8-K
| Quarterly results |
| 04/05/2017 |
SC 13D
| SCHOENBART ALAN WAYNE reports a 5.6% stake in ECHO THERAPEUTICS, INC. |
| 03/31/2017 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| 03/23/2017 |
4
| GOLDBERG MICHAEL M (Director) has filed a Form 4 on Echo Therapeutics, Inc.|
Txns:
| Granted 25,000 shares
@ $0 |
|
| 03/23/2017 |
4
| GOLDBERG SHEPARD M (Director) has filed a Form 4 on Echo Therapeutics, Inc. |
| 03/22/2017 |
4
| SCHOENBART ALAN WAYNE (CEO, CFO AND SECRETARY) has filed a Form 4 on Echo Therapeutics, Inc. |
| 03/22/2017 |
4
| SCHOENBART ALAN WAYNE (CEO, CFO AND SECRETARY) has filed a Form 4 on Echo Therapeutics, Inc. |
| 03/21/2017 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/02/2017 |
8-K
| Form 8-K - Current report |
| 12/27/2016 |
8-K
| Form 8-K - Current report |
| 12/14/2016 |
8-K
| Form 8-K - Current report |
| 12/02/2016 |
8-K
| Other Events |
| 12/01/2016 |
8-K
| Form 8-K - Current report |
| 11/23/2016 |
4/A
| SCHOENBART ALAN WAYNE (INTERIM CEO, CFO AND SECRETARY) has filed a Form 4 on Echo Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 11/23/2016 |
8-K
| Form 8-K - Current report |
| 11/16/2016 |
10-Q
| Quarterly Report for the period ended September 30, 2016 |
| 11/14/2016 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB |
| 10/19/2016 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ... |
| 09/27/2016 |
8-K
| Resignation/termination of a director |
| 09/26/2016 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 09/23/2016 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 08/12/2016 |
10-Q
| Quarterly Report for the period ended June 30, 2016 |
| 07/08/2016 |
8-K
| Form 8-K - Current report |
| 06/27/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 06/10/2016 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933 |
| 06/03/2016 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits |
| 05/26/2016 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 05/20/2016 |
10-Q
| Quarterly Report for the period ended March 31, 2016 |
| 05/13/2016 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans |
| 05/06/2016 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 05/04/2016 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregister... |
| 05/02/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 04/19/2016 |
8-K
| Form 8-K - Current report |
|